background preloader

New Medicines and improvements in old

Facebook Twitter

There's A New Antibiotic In Town, And We Can Create It In The Lab. The FDA Just Approved a Drug to Keep Us a Little Safer From A Possible Pandemic. UNTREATABLE NO MORE.

The FDA Just Approved a Drug to Keep Us a Little Safer From A Possible Pandemic

Fear of another smallpox pandemic keep you up at night? You’ll be happy to hear the FDA approved tecovirimat (Tpoxx) on Friday. It’s the first drug designed to treat the infectious disease, which kills about 30 percent of the people who contract it. Though not tested directly against smallpox in humans, in trials, the smallpox treatment did increase the survival rate of primates and rabbits injected with two similar diseases (monkeypox and rabbitpox, respectively). And the drug produced only minor side effects when evaluated on 359 healthy human volunteers. New Pill Kills the Flu Virus in 24 Hours. Is everything you think you know about depression wrong?

In the 1970s, a truth was accidentally discovered about depression – one that was quickly swept aside, because its implications were too inconvenient, and too explosive.

Is everything you think you know about depression wrong?

American psychiatrists had produced a book that would lay out, in detail, all the symptoms of different mental illnesses, so they could be identified and treated in the same way across the United States. It was called the Diagnostic and Statistical Manual. In the latest edition, they laid out nine symptoms that a patient has to show to be diagnosed with depression – like, for example, decreased interest in pleasure or persistent low mood.

World's First Malaria Vaccine Will Be Given to Thousands of Babies in Africa. In Brief Last week WHO announced that one of several potential malaria vaccines in development has made it through a crucial phase of trials and is now ready to be tested in the field.

World's First Malaria Vaccine Will Be Given to Thousands of Babies in Africa

The World Health Organization (WHO) is now one step closer to achieving their goal of eliminating malaria by 2040. Last week, WHO announced that one of several potential malaria vaccines in development has made it through a crucial phase in trials and is now ready to be field tested. In Phase 3 trials, the vaccine decreased mortality rates in 11,000 children in Sub-Sahara Africa by 50 percent, according to WHO data.

Antibiotic resistance: 'Snot wars' study yields new class of drugs. Image copyright Thinkstock A new class of antibiotics has been discovered by analysing the bacterial warfare taking place up people's noses, scientists report.

Antibiotic resistance: 'Snot wars' study yields new class of drugs

Tests reported in the journal Nature found the resulting drug, lugdunin, could treat superbug infections. The researchers, at the University of Tubingen in Germany, say the human body is an untapped source of new drugs. The last new class of the drugs to reach patients was discovered in the 1980s. Nearly all antibiotics were discovered in soil bacteria, but the University of Tubingen research team turned to the human body. IBM Medical Anti virus breakthrough could enable new mode of vaccination against all viruses. As one of medicine’s largest challenges, viral infections often escape vaccines due to their natural ability to mutate rapidly and develop drug resistance easily.

IBM Medical Anti virus breakthrough could enable new mode of vaccination against all viruses

Many viruses, such as Zika, Ebola and dengue fever, have grown into major global health epidemics with great human and economic toll. IBM Research and Singapore’s Institute of Bioengineering, Nanotechnology (IBN) announced they have identified a new breakthrough macromolecule that could help prevent deadly virus infections with a unique triple-play mechanism that can also help prevent viral drug resistance. The study exploits supramolecular chemistry – the study of large molecules designed with multiple features -- to help combat viral infection.

HIV-Proof for 6 Months: New Treatment Provides Long-Term Protection. In Brief A team of researchers injected four human antibodies into monkeys, and a week after, proceeded to inject them with primate HIV.

HIV-Proof for 6 Months: New Treatment Provides Long-Term Protection

The antibodies proved to be powerful enough to attack HIV, keeping the monkeys HIV-proof for 23 weeks. Antibodies, Not Vaccines The war against HIV and AIDS rages on, and we may have just taken another great step forward. New cancer drugs could treat lethal resistant prostate cancers. Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class of cancer drug designed to overcome drug resistance, a new study suggests.

New cancer drugs could treat lethal resistant prostate cancers

Researchers found that the drugs, called Hsp90 inhibitors, specifically target and inactivate a mechanism commonly used by prostate cancer cells to evade the effects of standard treatment. The findings provide vital information about the role of Hsp90 in drug-resistant prostate cancers, and open up potential new routes to cancer treatment based on blocking this or related proteins.

In New Anti-Aging Strategy, Clearing Out Old Cells Increases Life Span of Mice by 25 Percent. Wheelchair-bound multiple sclerosis patients able to walk again after stem-cell therapy. A pioneering new stem cell treatment is reversing and then halting the potentially crippling effects of multiple sclerosis.

Wheelchair-bound multiple sclerosis patients able to walk again after stem-cell therapy

Multiple sclerosis (MS) is the most common chronic neurological disease which affects predominantly young people and interferes with their personal and professional lives. The greatest number of cases occurs between the ages of 30 and 40 years of age. First New Antibiotic In 30 Years Could Prove Crucial In Fight Against Superbugs. Extreme Regenerative Medicine. Tweet A recent infographic looking at radical life extension mentioned head/body transplants.

Extreme Regenerative Medicine

Medical Marijuana - What’s It Good For? Interest in medical marijuana is growing steadily, fanned by a large political movement that aims to increase its availability and legality.

Medical Marijuana - What’s It Good For?

Pine bark substance could be potent melanoma drug. HERSHEY. Pa. -- A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers. Current melanoma drugs targeting single proteins can initially be effective, but resistance develops relatively quickly and the disease recurs.

In those instances, resistance usually develops when the cancer cell's circuitry bypasses the protein that the drug acts on, or when the cell uses other pathways to avoid the point on which the drug acts. Resistance to last-resort antibiotic has now spread across globe. Aging May Be Halted By Taking This Common Sports Supplement. Scientists in Switzerland have identified the genes responsible for aging and a longer lifespan, and may have uncovered possible therapies. Anti-aging science is moving at breakneck speed. Just last week the FDA approved an anti-aging drug trial for 2016 for the diabetes drug Metformin. 1,000-Year-Old Salve Recipe Kills MRSA Cultures.